Non Fiction publications

This page collates some of the non-fiction publications produced since 1990

Posterity - what you write for after being turned down by the publishers. - George Ade
Everyone is entitled to my opinion. - Anon!

Case studies produced under contract to the UK Dept. of Trade & industry to highlight their support for Biotechnology enterprises
The widely distributed booklet (left) detailed UK biotechnology initiatives e.g. LINK, SMART, Eureka, EU Framework, TCS, BEP & Bio-wise. (Don't apply now, these Programmes are long closed!). However they were open at the time for companies to apply and I have selected case studies which had received DTI financial R&D support. I collated the content and carried out the high end DTP for the booklet. The businesses covered were:

  • Ludger Ltd (Developed a kit for glycan analysis)
  • Abgene Ltd (Hot start DNA polymerases for PCR)
  • Chirotech Ltd (Developing thermostable enzymes for chemical syntheses)
  • Cypex Ltd (Developed a panel of liver enzymes to survey the metabolism of drugs in vitro).
  • Bradford Particle Design Ltd (Developing novel dry active particulate formulations of biologicals).
  • Ciba Speciality Chemicals Ltd (Environmentally friendly processing of acrylates for dye print industry).
  • Prometic Biosciences Ltd (Design and application of novel affinity ligands for purification of biologicals).
  • Charis Technology Ltd (Improved system for the measurement and control of biofermentation foams).
  • Remedios Ltd (Development of environmental biosensors using bioluminescent bacteria).
  • Cobra Therapeutics Ltd (Increasing the efficiency of gene expression for recombinant therapeutic proteins).
  • Oxford Instruments Lt ( Development of high frequency nuclear magnetic resonance (NMR) instruments).

It should be noted by anyone interested in the above firms that not all will still be trading, some will have changed their names or been absorbed by a large company (the frequent destiny of start-ups!) Also, please see my section on innovation for further comments in UK initiatives.

An altogether more extensive and intensive regular publication (Biotech LINK) was produced by me over a number of years under contract to the UK Laboratory of the Government Chemist (themselves contractors to the Department of Trade and Industry). This merits its own page and I will be adding to that as I do further research as to the results of that major UK Biotechnology initiative (several of the contributing companies are mentioned in the DTI case studies booklet above).


Hardback books!

I have published a number of technical and scientific books under various publishing houses or more recently, my own imprint. I have selected one which still has some mileage and may be available from IRL press or online.

This book, edited by myself and Professor John Findlay (Leeds University) had chapters contributed by international leaders in this specialised field and sold well despite the expertise required and the expense of the equipment!

Today this activity is an essential requirement in the research, development and quality assessment and control of recombinant therapeutic proteins and peptides. So much so that I have included this analysis in my page on bioinstrumentation

Not illustrated here, I have also edited collaborative books on microcomputers in medicine

A guide for those who would like to carry out highly sensitive amino acid sequence determination

The newsletter is still a useful means of forging links within and between industry and academia and promoting gatherings

Of potential interest to any of my readers "going it alone" as life sciences consultants, I produced a range of newsletters (doing the content research, design and DTP "in house") over the years for HUGO: the Human Genome Organisation, The European Commission, The Biochemical Societies Peptide Group, The LINK Cell Engineering initiative amongst others.

I had very good feedback and commend this type of communication, which can be produced easily using even low cost DTP.

It may well be that the blog or vlog is the preferred analogous communication today, but with the proviso that there are so many blogs online that it can be like looking for a needle in a haystack. An advantage of the newsletter is that it can be mailed out with other regular communications to existing subscribers. In large entities (research institutes, start-ups, large or multinational companies) this sort of communication is useful to circulate within the relevant organisation. At Delta Biotechnology where I worked in the early 90s, our research director generated a scurrilous in house broadsheet with the aim of boosting morale!

Some of my newsletters were produced under contract, others were simply my private initiative! The aim being to raise awareness, foster contacts and advertise workshops, meetings or major conferences. Even now after Zoom and the ready availability of all kinds of information via the Web, printed matter persists and somehow has more permanence than the ephemeral Internet. At least print is is independent of network downtime!

Biomaterials newsletter produced under contract to the Laboratory of the Government Chemist
Genome Digest: Launch issue of the Human Genome Programme newsletter (edited with Mary Purton)
Newsletter produced for the Peptide Group of the UK Biochemical Society
Newsletter for the Structural Biology in Europe newsletter (Produced while I was secretary of what the Commission termed an " Industrial Platform")

The Structural Biology in Europe Industrial Platform was a sort of spin-off from the Protein Engineering Contact Group. I concocted the acronym "STRUBE" for my newsletter evidently having been affected by the European Commission's tendency to acronymise all their various initiatives - see my page on innovation.

The Structural Biology Industrial Platform met, with considerable interest and pleasure in a number of host companies: (Philips in Eindhoven, Silicon Graphics in Switzerland to name two) but the need for this particular platform was soon eclipsed by the up swell of structural genomics and proteomics gatherings that were obviously of higher value to the firms participating in the Industrial platform and STRUBE was terminated after a couple of years.